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The epidemiology of cruciate 
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Cruciate ligament rupture (CLR) is a common orthopedic disorder in dogs. The study objectives 
were to evaluate incidence rate (IR), cause-specific mortality rate (CSMR) and risk factors for CLR in 
insured dogs. A single cohort study of dogs insured in Agria Pet Insurance in Sweden (2011–2016) was 
performed. Age at diagnosis, IR, CSMR and relative risk (RR) for CLR was calculated overall and per 
breed. The cohort included just over 600,000 dogs. The IR of CLR was 23.8 (95% confidence interval, 
23.1–24.6) cases per 10,000 DYAR. The breeds with highest RR of CLR were Boerboel and Dogo 
Canario, while the breeds with lowest RR were Standard Dachshund and Miniature Pinscher. Dogue 
de Bordeaux had highest RR of euthanasia due to CLR. The median age at veterinary care claim for 
CLR was 7.1 (range 0.3–16.0) years and 6.6 (0.3–12) years at life insurance settlement. Large and giant 
breeds were generally diagnosed and euthanized due to CLR at a younger age compared to smaller 
breeds. The majority of the breeds with increased RR of CLR diagnosis and CLR-related euthanasia 
were large or giant. A pattern of increasing size and decreasing age at diagnosis/CLR-related 
euthanasia was observed.
Cranial cruciate ligament disease (CCLD) is among the most common orthopedic disorders in  dogs1, and the 
most common stifle joint disease requiring veterinary  care2. Many factors, including anatomical configuration, 
environment and genetics, are suggested to contribute to development of CCLD, and the complex and likely 
multifactorial origin of the disease makes it challenging to develop preventive  strategies3–5. The condition can 
be treated either surgically or conservatively, and there are over 60 variations of surgical procedures  described6. 
The treatment is often costly; it was estimated that the total cost of CCLD treatment in the US during 2003 was 
1.32 billion  dollars7. Rupture of the caudal cruciate ligament with intact cranial cruciate ligament is much more 
uncommon, and is often caused by  trauma1,8.
The reported prevalence of CCLD varies between 0.56–2.55%9–11. However, these prevalence estimates are 
based on data from veterinary clinics, which may represent a biased proportion of dogs from the general dog 
population. Population based estimates of disease occurrence are necessary in order to evaluate the impact of 
CCLD at a population level. Insurance data are feasible for such calculations, given that a sufficient proportion 
of the dog population is insured. In Sweden, 77% of all dogs were covered by veterinary care insurance during 
2012, and during 2016 38% of the dog population was insured in Agria Pet  Insurance12,13. The Agria Pet Insurance 
database has been used in epidemiological studies of conditions such as atopic dermatitis, dystocia, epilepsy, 
and adrenocortical  insufficiency14–17.
Several breeds such as Rottweiler, Labrador Retriever and Newfoundland are reported as predisposed to 
CCLD, and the disease often affects middle-aged to older dogs with a reported median age of 4.3–7.0 years at 
 presentation9,11,18,19. Females and neutered dogs are generally reported as predisposed to the  condition9–11,19,20. 
Comorbidities such as hip dysplasia and patellar luxation have been described in dogs with CCLD, but if these 
comorbidities act as risk factors for CCLD is not fully  evaluated9,21–23.
Even though the long-term treatment results for CCLD generally are reported as successful, the disease fre-
quently results in osteoarthritis and chronic pain, which in severe cases could result in  euthanasia24–26. There is 
limited information about euthanasia due to CCLD, but one study reported a cause-specific mortality of 2 cases 
per 10,000 dog-years at risk (DYAR) in dogs insured in Agria Pet Insurance 1995–200027. A study including 
Norwegian and Swedish dogs treated for CCLD at two University Animal Hospitals reported that 61 of the 333 
included dogs (18.3%) were euthanized for reasons related to CCLD at some point after treatment  initiation22. 
The most common reason for CCLD-related euthanasia was persistent lameness from the affected limb. Many 
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studies have reported that the risk of CCLD varies with breed, but it is not known if the same applies to the risk 
of CCLD-related euthanasia.
The objective of the study was to provide population-based estimates of incidence rate, cause-specific mortal-
ity rate, and age at diagnosis of cruciate ligament rupture (CLR) for dogs insured in Agria Pet Insurance (Agria 
Djurförsäkring, Stockholm, Sweden) in Sweden. Additional aims were to investigate whether the affected dogs 
had claims for other diagnoses prior to the CLR, and if the age at diagnosis and relative risk (RR) of CLR varied 
with breed. The diagnostic codes of the claims in the Agria Pet Insurance database are based on a hierarchical 
diagnostic registry developed by the Swedish Association of Veterinary Clinics and  Hospitals28, and do not 
differentiate between cranial and caudal cruciate ligament rupture. Caudal cruciate ligament rupture has been 
reported as much more uncommon than  CCLD1, and a recent report shows that damage to the caudal cruciate 
ligament in dogs with CCLD is common, which suggests a mutual underlying pathogenic  mechanism29. Thus, 
the results of the current study will be compared to studies evaluating only CCLD.
Materials and methods
Data. This was a single cohort study comprising data on dogs insured in Agria Pet Insurance in Sweden 
between January 1, 2011 and December 31, 2016. There were two types of insurances—veterinary care and life. 
The data collected included information about breed, sex (female/male, but not neuter status), date of enroll-
ment and termination of the insurance, age at start of the observation period and date and diagnostic codes for 
veterinary care claims and life insurance settlements (if any). The life insurance terminated at 8, 10 or 12 years of 
age, depending on breed (see supplementary Table 1). The dogs could be enrolled in veterinary care insurance at 
any age, but in life insurance only before the age of 4 years (for breeds with insurance termination at 8 years) or 
6 years (all other breeds). The age at observation start was based on the median age in the population at 1 Janu-
ary, 2011. The breed variable was based on the classification by Federation Cynologique Internationale (FCI) 
and the Swedish Kennel Club (SKC). Seven breeds were non-approved by both FCI and the SKC; Old English 
Bulldog, American Bulldog, Boerboel, Pitbull Terrier, Alaskan Husky, Hedehund and Griffon à Poil Laineux/
Boulet. All available breeds were included in the analysis.
The deductible of the veterinary care insurance was chosen by the owner at insurance enrollment, and the 
claims were registered by a clerk at the company if the total cost of all veterinary appointments during rolling 
125-days periods exceeded the deductible. In case receipts from several veterinary appointments were submitted 
at the same time, they were usually registered as separate claims on the same date. Claims for non-traumatic CLR 
were reimbursed only after a waiting period of 12 months after insurance enrollment in dogs insured after the 
age of four months. Two diagnostic codes were included in the database search: “Cruciate ligament rupture” and 
“Cruciate ligament rupture, several joints”. Since it was not possible to differentiate between cranial and caudal 
cruciate ligament rupture in the database, different terminology will be used when the results are compared to 
results from other studies; CLR for the current study, and CCLD for studies evaluating only CCLD.
The age at diagnosis was based on the first registered veterinary care claim for CLR during the observation 
period or the date when a life insurance settlement was registered in the database. In addition, all claims for other 
conditions were extracted and included in the analysis for dogs with veterinary care claims for CLR. There was 
no information about claims before the start of the observation period, and claims for diseases present before 
insurance enrollment were not reimbursed. Settlement of life insurance required a certificate from the veterinar-
ian, sometimes in combination with an autopsy depending on the cause of death. Euthanasia and natural death 
were not distinguished in the database. Dogs were excluded in case of uncertain information about age, sex, breed 
or date of insurance enrollment (for example dogs with date of insurance enrollment before date of birth etc.).
Analysis. Data analysis was performed in RStudio version 1.2.133530. Continuous variables are presented as 
median (range) and categorical variables as number (percentage). Wilcoxon rank-sum test was used to compare 
median age between groups, since the Shapiro–Wilk test showed that the age variable was not normally distrib-
uted. Two-sided one sample z test of proportions was used to compare proportions. Dog-years at risk (DYAR) 
was based on the total insurance duration for each dog during the study period (2011–2016). For incidence 
calculation, the DYAR in dogs with CLR claims during the study period was based on the time period until the 
first CRL claim. The incidence rates and cause-specific mortality rates were expressed as the number of dogs 
with veterinary care claims or life insurance settlements due to CLR per 10,000 DYAR. Relative risk for breed 
was calculated by dividing the incidence rate/cause-specific mortality rate for the breed by the incidence rate/
cause-specific mortality rate of the rest of the population (with the breed excluded). Relative risk for sex was 
calculated similarly. Confidence intervals (CI) were calculated with the R-package “exactci” (version 1.3-3)31 
based on the Poisson distribution. Bonferroni correction, based on the number of subgroups included in the 
comparison, was used to adjust for multiple comparisons. P-values < 0.05, after corrections, were considered 
to indicate statistically significant differences. Breed risks were described using forest plots from the R-package 
“forestplot” (version 1.9)32.
Results
The database included just over 600,000 insured dogs, and 649 dogs were eliminated due to the exclusion cri-
teria. The majority of the dogs (61.8%) had both veterinary care and life insurance, while the remaining dogs 
had only veterinary care insurance (35.5%) or life insurance (2.7%). Descriptive features of the dog population 
are presented in Table 1.
The overall incidence rate of CLR was 23.8 (95% CI, 23.1–24.6) cases per 10,000 DYAR. In total, 181 breeds 
had at least one dog with a veterinary care claim for CLR. Of these, 26 breeds had significantly increased risk 
of CLR, while 18 breeds had significantly decreased risk (that is, RR either significantly higher or lower than 1) 
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after Bonferroni correction (Fig. 1, for a full list without Bonferroni correction, see supplementary Table 3). The 
breeds with highest risk of CLR were Boerboel (RR 11.0, 95% CI, 5.84 – 18.8) and Dogo Canario (RR 7.92, 95% 
CI, 3.42–15.6) and the breeds with lowest risk were the Standard Dachshund (RR 0.07, 95% CI, 0.03–0.13) and 
the Miniature Pinscher (RR 0.05, 95% CI, 0.00–0.28).
Female dogs were at increased risk of having a CLR veterinary care claim compared to male dogs (RR 1.13, 
95% CI, 1.06–1.20, p < 0.001). Of the 4167 dogs with veterinary care claims for CLR, 2762 (66.3%) had a concur-
rent life insurance. Of these, 466 dogs had a life insurance settlement during the observation period, of which 
234 (50.2%) were due to CLR. Median time from CLR veterinary care claim to life insurance settlement due to 
CLR was 7 days (0–4.25 years). Time from diagnosis of CLR to euthanasia varied with age at diagnosis; it was 
significantly shorter in dogs diagnosed > 9 years of age, compared to dogs diagnosed < 3 years of age (p = 0.0086).
The age at diagnosis and at life insurance settlement due to CLR varied with breed. Breeds with a median age 
that differed significantly from all other breeds are presented in Table 2. In general, the breeds with significantly 
lower age at diagnosis were large and giant breeds, while the breeds with significantly higher age at diagnosis 
were small breeds. The same pattern was seen for the age at euthanasia. The dogs with life insurance settlements 
due to CLR were significantly younger at time of death/euthanasia, than dogs with life insurance settlement for 
all other reasons (6.61 (range, 0.31–12.0) years versus 7.53 (0.19–12.83) years, p < 0.001).
In total, 2656 of the 4167 (63.7%) dogs with veterinary care claims for CLR had previous claims for other 
diseases. The frequency and distribution of veterinary care claims by organ system is presented in Table 3, with 
comparison to claims in veterinary care-insured dogs without CLR. Of the 4167 dogs with CLR, 1542 (37.0%) had 
previous claims for musculoskeletal disorders and 1093 (26.2%) for dermatologic conditions. The most common 
diagnoses within these organ systems were joint disease and neoplastic skin disease, which affected 913 (21.9%) 
and 292 (7.01%) of the dogs with veterinary care claims for CLR, respectively (Tables 4 and 5).
The cause-specific mortality rate was 4.04 (95% CI, 3.67–4.43) deaths per 10,000 DYAR, and 99 breeds had 
at least one dog with a life insurance settlement due to CLR. There were 7 breeds with significantly increased RR 
and 1 breed with significantly decreased RR of euthanasia due to CLR after Bonferroni correction (Fig. 2 and 
supplementary Table 4, which consist a full list without Bonferroni correction). The breeds with highest risk of 
euthanasia due to CLR were the Dogue de Bordeaux (RR 30.4, 95% CI, 16.5–51.5) and the Cane Corso (RR 12.7, 
95% CI, 7.04–21.2), while the breed with lowest risk was the Standard Dachshund (RR 0, 95% CI, 0–0.26). There 
was no difference in risk of euthanasia due to CLR in females compared to males (RR 1.12, 95% CI, 0.93–1.36, 
p = 0.24). Approximately half of the dogs with life insurance settlements due to CLR (52.3%) had a veterinary 
care claim for CLR at some point before the life insurance settlement.
Discussion
The current study demonstrated large breed-specific differences in incidence rate, cause-specific mortality rate 
and age at diagnosis of CLR. The breeds with highest RR of CLR were Boerboel, Dogo Canario, American and 
English Bulldog, Dogue de Bordeaux, Bullmastiff, Chow Chow, Rottweiler and Cane Corso. Some of these breeds, 
such as the Rottweiler, English Bulldog and Chow Chow, are commonly reported as predisposed to CCLD in 
other studies, together with Newfoundland, Boxer, Staffordshire Bull Terrier, American Staffordshire Terrier and 
Yorkshire Terrier, which all are among the high-risk breeds in the current  study9,11,19. Several of the identified 
low-risk breeds, for example the Cocker Spaniel, German Shepherd Dog, Chihuahua, Miniature Schnauzer, 
Shih Tzu, English Springer Spaniel, Pug and Standard Dachshund, are also reported as low-risk breeds in other 
 studies11,19,20. Previous reports about the risk of CCLD for the Labrador Retriever are conflicting; some studies 
report the Labrador Retriever as a high-risk  breed9,19,20, while others found no increased  risk11,33. In the current 
study, the Labrador Retriever had a slightly increased RR of CLR. The difference in results may be due to differ-
ences in study design and study populations, or regional differences in disease pattern.
Some of the high-risk breeds in the current study, such as Boerboel and Dogo Canario, have not been pre-
viously reported as predisposed to CCLD. These breeds were represented by relatively few individuals in the 
Table 1.  Descriptive features of dogs insured in Agria Pet Insurance in Sweden, 2011–2016. *Per dog, during 
2011–2016. **Age at first CLR claim during 2011–2016 for dogs with veterinary care insurance. CLR cruciate 
ligament rupture, y years, w weeks.
Insurance
Veterinary care Life
Total duration of insurance (years)  > 1.7 million  > 1.1 million
Insurance duration, median (range)* 2.7 y (9.1 w–6.0 y) 2.5 y (9.1 w–6.0 y)




Number of dogs with claims for CLR 4167 447
 CLR 4142 432
 Bilateral CLR 45 15
Age at CLR claim, median (range)** 7.1 y (13.3 w–16 y) 6.6 y (16.3 w–12 y)
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Figure 1.  Dog breeds with increased or decreased relative risk (RR) of a veterinary care claim for cruciate 
ligament rupture (relative to the rest of the population with the breed excluded) in a cohort of dogs insured 
in Agria Pet Insurance in Sweden (2011–2016). All RRs in the figure were significantly different from 1, after 
Bonferroni correction based on the number of breeds included in the comparison, n = 339. Note that RR = 0.5 
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insured dog population, but increased in popularity during the observation period (based on increasing DYAR/
year, data not shown). It is possible that these breeds were too uncommon to be identified as high-risk breeds in 
older studies, and that more recent studies, but with smaller study populations, had too low power to identify 
Table 2.  Median age in years (range) at first veterinary care claim for cruciate ligament rupture (CLR) or 
at life insurance settlement due to CLR during the observation period (2011–2016) in a cohort of insured 
Swedish dogs. *The median age at veterinary care claim for CLR in the listed breeds differed significantly from 
the median age in all other breeds after Bonferroni correction (based on the number of breeds included in 
the comparison, n = 181). For a full list of breeds with significantly higher/lower median age at veterinary care 
claim without Bonferroni correction, see supplementary Table 2. **The only breed with median age at CLR 
life insurance settlement that differed significantly from the median age of all other breeds, after Bonferroni 
correction (based on the number of breeds included in the comparison, n = 99). The other listed breeds had 
a median age at life claim that differed significantly from the median of all other breeds, without Bonferroni 
correction.
Veterinary care insurance Life insurance
Breed
Age* at first CLR 
claim Breed Age at CLR claim
Boerboel 1.98 (1.08–3.98) Dogo Canario 1.86 (1.81–1.92)
English Bulldog 2.65 (0.79–9.63) English Bulldog 2.63 (1.93–4.11)
French Bulldog 2.67 (0.25–10.3) Dogue de Bordeaux** 3.11 (1.48–8.42)
Cane Corso 2.68 (0.56–9.11) Cane Corso 3.15 (1.08–8.71)
American Staffordshire Terrier 3.56 (0.44–11.5) Bullmastiff 3.43 (1.30–4.93)
American Bulldog 3.56 (1.44–7.79) Newfoundland 3.97 (1.25–6.81)
Bullmastiff 3.72 (0.95–6.95) Rottweiler 4.99 (0.65–9.87)
Dogue de Bordeaux 3.92 (1.01–7.06) Medium Poodle 8.98 (7.87–11.5)
Staffordshire Bull Terrier 4.75 (0.50–13.6) Bolognese 9.07 (7.24–9.93)
Boxer 4.92 (0.29–10.4) Cairn Terrier 9.22 (7.08–10.6)
Rottweiler 5.15 (0.30–11.6) Miniature and Toy Poodle 9.30 (1.62–10.0)
Jack Russell Terrier 8.44 (0.78–14.5) Standard Poodle 9.90 (9.72–10.1)
Bichon Frise 8.81 (2.90–14.5) Soft Coated Wheaten Terrier 10.5 (9.11–12.0)
Border Terrier 9.37 (1.61–13.1) Border Terrier 10.9 (9.41–11.9)




West Highland White Terrier 11.1 (5.13–13.2)
Tibetan Spaniel 11.3 (2.68–12.7)
Table 3.  Previous diagnoses by organ system in dogs with and without cruciate ligament rupture (CLR), in a 
cohort of dogs insured in Agria Pet Insurance (2011–2016). *The proportion of dogs with diagnoses in these 
organ systems was significantly higher in dogs with CLR, after Bonferroni correction based on the number of 
organ systems, n = 12. **In total 4167 dogs with veterinary care claims for CLR. ***All dogs with veterinary 
care insurance, except for the dogs with CLR claims.
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Table 4.  Previous musculoskeletal diagnoses in dogs with veterinary care claims for cruciate ligament rupture 
(CLR) in Agria Pet insurance (2011–2016). *In total 4167 dogs with veterinary care claims for CLR. All 
subcategories for stifle joint diagnoses are presented. For all other categories the most specific subcategory is 
presented, even though pain/signs without confirmed cause was generally the most common subcategory.
Category % of dogs with CLR*
Joint disease 21.9
Stifle 15.6
   Pain/signs without confirmed cause 8.18
   Degenerative changes 3.14
   Arthritis 2.30
   Patellar luxation 2.14
   Meniscal injury 0.79
   Traumatic injuries 0.70
   Osteochondrosis 0.22
   Fracture 0.02
   Neoplastic disease 0.02
Hip 2.93
   Hip dysplasia 0.84
Elbow 2.26
   Degenerative changes 0.98
Phalanges 1.30
   Degenerative changes 0.26
Several (unspecified) joints 1.13




   Traumatic injuries 0.24
Tarsus 0.55







   Traumatic injuries 0.41
Table 5.  Previous dermatologic diagnoses in dogs with veterinary care claims for cruciate ligament rupture 
(CLR) in Agria Pet insurance (2011–2016). *In total 4167 dogs with veterinary care claims for CLR.
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these breeds as high-risk. Our findings may also be a result of regional differences in disease pattern, or an actual 
increase in CLR incidence within these breeds, but our data was not sufficient to investigate such time trends.
The majority of the breeds with highest RR of CLR were large or giant breeds, even though several small 
breeds such as Bichon Frise, Bolognese and Yorkshire Terrier were among the high-risk breeds. The breeds with 
low risk of CLR also varied in size from small to large, but the giant breeds were only represented among the 
high-risk breeds. This indicates that other factors than body size contribute to the development of CCLD, but that 
giant dogs may be at higher risk compared to dogs of smaller sizes. The fact that certain breeds have increased 
risk of CLR, irrespective of size, suggests a genetic component to the etiology of the disease, which already has 
been shown for CCLD in the Newfoundland and the Labrador  Retriever4,34. The same pattern was seen among 
the dogs with increased risk of euthanasia due to CLR, where all of the high-risk breeds were large or giant. 
Increasing body weight has been associated with higher risk of euthanasia due to  CCLD22. This association may 
be explained by several factors. For example, the risk for postoperative complications after surgical treatment of 
CCLD increase with increasing body  weight35–41, and such complications could potentially result in euthanasia 
in severe cases. In addition, the recovery period after CCLD in a large, heavy dog may be challenging for the 
owners, as the dog may need to be carried up stairs etc., which can be difficult given the dog’s weight. This could 
also contribute to a decision of euthanasia.
Female dogs were at increased risk of CLR compared to male dogs in the current study, which is supported 
by previous  reports10,19. However, many studies report increased risk of CCLD in neutered dogs compared to 
 entire9,11,20. The effect of neutering could not be evaluated in the current study, due to lack of information about 
neuter status in the insurance database. In a survey of the Swedish dog population performed > 20 years ago, 
only 7.2% of the female dogs and 3.7% of the male dogs were  neutered42. A more recent study conducted during 
the study period (2012) concluded that 22.3% (± 4.8%) of the dogs were neutered, with no separation of female/
male  dogs12. Neuter status could potentially have a confounding effect on the association between sex and CLR, 
if females were neutered to a higher extent than males in the study population.
The median age at diagnosis of CLR was 7.1 years, which is largely in accordance with previous  studies11,18. 
There were large breed-specific differences in age at diagnosis; the majority of the breeds with significantly lower 
age at diagnosis were large or giant, while the majority of the breeds with significantly higher age at diagnosis 
were small. Information about age at CLR diagnosis by breed is limited in the literature, but a pattern of increas-
ing weight and decreasing age at diagnosis has been  described19,20. Rottweilers have been reported as younger 
than other breeds at time of  presentation18. In addition, several of the breeds with a significantly lower age at 
diagnosis in the current study (English Bulldog, American Staffordshire Terrier, and Rottweiler) were reported 
as predisposed to CCLD in a study investigating breed as a risk factor for the CCLD in dogs under two years 
of  age20. The age at euthanasia due to CLR showed a similar pattern of increasing size of the breed and decreas-
ing age at euthanasia. Larger dogs generally have a shorter lifespan than smaller, since increasing body weight 
is negatively correlated with  longevity43. Thus, a large breed dog may be perceived as “old” at a younger age 
Figure 2.  The breeds with increased or decreased relative risk (RR) of death/euthanasia due to cruciate 
ligament rupture (relative to the rest of the population with the breed excluded) in a cohort of dogs insured in 
Agria Pet Insurance in Sweden during 2011–2016. All RRs in the figure were significantly different from 1, after 
Bonferroni correction based on the number of breeds included in the comparison, n = 335. Note that RR = 0.5 
means 2 times decreased risk, RR 0.125 means 8 times decreased risk and so on. A fudge factor of 0.01 was 
added to the RR of Standard Dachshund in order to present the RR on the log-scaled x axis. DYAR dog-years at 
risk, CI confidence interval.
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compared to a smaller dog, which may affect the treatment recommendation by the examining veterinarian and 
the owner’s decision of euthanasia. However, this was probably not the main reason for euthanasia, since the 
median age at time of euthanasia in several of the large and giant breeds was below four years. Further studies 
on the connection between age, breed and CLR are warranted.
About 2/3 of the dogs with veterinary care insurance claims for CLR had previous claims for other diseases. 
Almost 16% had claims for stifle joint disease, and the most common diagnoses were related to pain/signs 
without confirmed cause, degenerative joint disease and arthritis. It is likely that some of these diagnoses were 
in fact undiagnosed CCLD, as the cranial drawer test used to diagnose CCLD can be negative in a conscious 
dog despite a ruptured  ligament44. Another explanation is that the CCLD is the result of a chronic degenerative 
process, which may have been a reason for the preceding  visits29,45. Some diagnoses, i.e. within the musculoskel-
etal, dermatologic, gastrointestinal, urogenital, ophthalmic and hepatic organ system as well as other, general 
diagnoses affecting the whole body (such as fatigue), were more common in dogs with CLR compared to dogs 
without CLR. It is possible that some of these disorders or their associated treatments predisposed to CLR. For 
example, glucocorticoids are commonly prescribed for long-term treatment of conditions such as atopic der-
matitis, and it is known that ligament rupture is a clinical manifestation of hyperadrenocorticism in  dogs46–48. 
It is also possible that these diagnoses share common risk factors with CLR. For example, large or giant breeds 
are reported as more likely to develop both HD, osteoarthritis and  CCLD9,49. Causal inference between previous 
diagnoses and the subsequent CLR cannot be drawn, due to the retrospective nature of the study. Despite this, it 
is important to know that many dogs with CLR had previous or concurrent comorbidities at time of diagnosis. 
These comorbidities could affect the prognosis for returning to adequate function and mobility, and thus affect 
the recommendation/decision of treatment by the examining veterinarian and the owner.
There is limited information about cause-specific mortality of CLR in the literature. Even though one should 
be cautious with direct comparisons between studies, the cause-specific mortality rate of 4.04 (95% CI, 3.67–4.43) 
deaths per 10,000 DYAR in the current study was higher than the 2 deaths per 10,000 DYAR reported in a study 
of mortality in the Agria Pet Insurance database 1995–200027. One possible explanation for the increased mor-
tality is increasing veterinary tariffs and the development of advanced surgical treatment options for CCLD. 
This causes an increased financial burden on the animal owner, who may have chosen euthanasia over a high 
cost treatment to a higher extent during the study period than > 20 years ago. Of the dogs with CLR life insur-
ance settlements, only 53.1% had a previous veterinary care claim for CLR. It is possible that the dogs without 
a previous veterinary care claim for CLR had gone through a nonsurgical treatment of the CLR with costs not 
reaching the deductible of the insurance, since nonsurgical treatment of CLR generally is less costly than surgi-
cal  treatment7. Another possible explanation is that some of the dogs had a CLR veterinary care claim before 
the start of the observation period. Still, it is likely that some dogs were euthanized at time of CLR diagnosis. 
Over 50% of the dogs that had a veterinary care claim for CLR and a subsequent life insurance settlement were 
euthanized due to CLR. The median time from CLR diagnosis to CLR-related euthanasia was 7 days. Some dogs 
were euthanized at the day of CLR diagnosis, while the maximum time between diagnosis and euthanasia was 
4.25 years. The fact that some dogs had several weeks or years between diagnosis and euthanasia may imply that 
treatment failures occur, and result in euthanasia.
Although insurance data are valuable for epidemiology research, some limitations should be mentioned. Agria 
Pet Insurance database was validated against practice records > 20 years  ago50. The validation showed excellent 
agreement for sex and breed but fair agreement for birth date, with a tendency of better agreement for clinics with 
computerized medical records. Since computerized medical records are used in the majority of Swedish clinics 
today, the current agreement is most likely better. The dataset generally has high statistical power, but significant 
associations in breeds represented by few individuals will have been found only if the CCLD incidence of the 
breed is very high. Even though the dataset is large, it is important to consider the precision of the estimates when 
the results are interpreted, which can be done by evaluating the width of the confidence intervals.
The reporting of claims relies on the examining veterinarians, who all have different routines for clinical 
examinations and diagnostic procedures. There is a risk that some of the dogs with CLR were reported under 
more unspecific diagnostic codes, such as “Lameness, without further specification”. Thus, the incidence rate 
and cause-specific mortality rate of CLR are probably slightly underestimated. There is also a risk that age at life 
insurance settlement is underestimated, if dogs were euthanized due to CLR after termination of the life insur-
ance. Increasing bodyweight within breed has been associated with increased odds of  CCLD11, but could not be 
evaluated in the current study due to lack of information in the database.
Even though there was a separate diagnostic code for bilateral cruciate ligament rupture, it was rarely used. 
One study of Labrador Retrievers with CCLD reported a frequency of bilateral rupture at initial presentation 
of 10.6%, and that subsequent rupture occurred in almost 50% of the  dogs51. In another study, 54% of the dogs 
developed contralateral  CCLD52. It is likely that the code “Cruciate ligament rupture” was used for dogs with 
bilateral rupture in the current study, especially in case of subsequent rupture. Consequently, the true occurrence 
of bilateral CLR was probably higher than reported. Contralateral CLR has been shown to affect the decision 
of euthanasia in dogs with  CCLD22. Thus, there is a risk that bilateral rupture had a confounding effect on the 
association between breed and mortality due to CLR, if some breeds were affected by bilateral rupture to a higher 
extent than others.
Morbidity and mortality of insured dogs may not reflect mortality and morbidity in uninsured  animals53. For 
example, a study that evaluated CCLD in dogs attending primary-care practices in England reported increased 
odds of a diagnosis in insured dogs, compared to in  uninsured11. It is not known if the same pattern exists in 
dogs insured in Sweden. However, the results of our study are probably representative for the majority of the 
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Conclusion
In conclusion, CLR affected more than 4000 dogs in the population, with an incidence of 23.8 (95% CI, 23.1–24.6) 
cases per 10,000 DYAR. Although dogs of all sizes were affected, the majority of the breeds with increased RR of 
CLR were large or giant. Large and giant breeds also had an increased risk of euthanasia due to CLR, and were 
generally diagnosed and euthanized due to CLR at a younger age compared to smaller breeds. Demographic 
factors associated with CLR provide guidance for veterinarians in their clinical work, and may educate breed-
ers and dog owners about breeds at risk of disease. In addition, the results may guide studies investigating the 
aetiopathogenesis of CLR. Given the identified breed predispositions, which likely has a genetic component, 
breeds reforms may be warranted in the future to lower the incidence of CLR.
Data availability
The data analyzed in the current study are not publicly available due to a non-disclosure agreement with Agria 
Pet Insurance.
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